Statera Biopharma Stock Technical Analysis
| STAB Stock | USD 0.0004 0.0002 100.00% |
As of the 12th of February 2026, Statera Biopharma has the Semi Deviation of 21.85, risk adjusted performance of 0.1988, and Coefficient Of Variation of 419.4. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Statera Biopharma, as well as the relationship between them.
Statera Biopharma Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Statera, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to StateraStatera |
Statera Biopharma 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Statera Biopharma's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Statera Biopharma.
| 11/14/2025 |
| 02/12/2026 |
If you would invest 0.00 in Statera Biopharma on November 14, 2025 and sell it all today you would earn a total of 0.00 from holding Statera Biopharma or generate 0.0% return on investment in Statera Biopharma over 90 days. Statera Biopharma is related to or competes with HST Global. Statera BioPharma, Inc., a clinical-stage biopharmaceutical company, develops novel immunotherapies targeting autoimmune... More
Statera Biopharma Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Statera Biopharma's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Statera Biopharma upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 66.41 | |||
| Information Ratio | 0.2365 | |||
| Maximum Drawdown | 275.0 | |||
| Value At Risk | (66.67) | |||
| Potential Upside | 100.0 |
Statera Biopharma Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Statera Biopharma's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Statera Biopharma's standard deviation. In reality, there are many statistical measures that can use Statera Biopharma historical prices to predict the future Statera Biopharma's volatility.| Risk Adjusted Performance | 0.1988 | |||
| Jensen Alpha | 12.74 | |||
| Total Risk Alpha | 6.31 | |||
| Sortino Ratio | 0.1867 | |||
| Treynor Ratio | (4.69) |
Statera Biopharma February 12, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1988 | |||
| Market Risk Adjusted Performance | (4.68) | |||
| Mean Deviation | 33.71 | |||
| Semi Deviation | 21.85 | |||
| Downside Deviation | 66.41 | |||
| Coefficient Of Variation | 419.4 | |||
| Standard Deviation | 52.43 | |||
| Variance | 2748.4 | |||
| Information Ratio | 0.2365 | |||
| Jensen Alpha | 12.74 | |||
| Total Risk Alpha | 6.31 | |||
| Sortino Ratio | 0.1867 | |||
| Treynor Ratio | (4.69) | |||
| Maximum Drawdown | 275.0 | |||
| Value At Risk | (66.67) | |||
| Potential Upside | 100.0 | |||
| Downside Variance | 4409.72 | |||
| Semi Variance | 477.24 | |||
| Expected Short fall | (113.64) | |||
| Skewness | 1.72 | |||
| Kurtosis | 3.93 |
Statera Biopharma Backtested Returns
Statera Biopharma is out of control given 3 months investment horizon. Statera Biopharma owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.24, which indicates the firm had a 0.24 % return per unit of risk over the last 3 months. We were able to analyze twenty-seven different technical indicators, which can help you to evaluate if expected returns of 12.7% are justified by taking the suggested risk. Use Statera Biopharma Coefficient Of Variation of 419.4, risk adjusted performance of 0.1988, and Semi Deviation of 21.85 to evaluate company specific risk that cannot be diversified away. Statera Biopharma holds a performance score of 19 on a scale of zero to a hundred. The entity has a beta of -2.66, which indicates a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Statera Biopharma are expected to decrease by larger amounts. On the other hand, during market turmoil, Statera Biopharma is expected to outperform it. Use Statera Biopharma coefficient of variation, maximum drawdown, skewness, as well as the relationship between the total risk alpha and downside variance , to analyze future returns on Statera Biopharma.
Auto-correlation | -0.12 |
Insignificant reverse predictability
Statera Biopharma has insignificant reverse predictability. Overlapping area represents the amount of predictability between Statera Biopharma time series from 14th of November 2025 to 29th of December 2025 and 29th of December 2025 to 12th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Statera Biopharma price movement. The serial correlation of -0.12 indicates that less than 12.0% of current Statera Biopharma price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.12 | |
| Spearman Rank Test | 0.17 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Statera Biopharma technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
Statera Biopharma Technical Analysis
The output start index for this execution was one with a total number of output elements of sixty. The Normalized Average True Range is used to analyze tradable apportunities for Statera Biopharma across different markets.
About Statera Biopharma Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Statera Biopharma on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Statera Biopharma based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Statera Biopharma price pattern first instead of the macroeconomic environment surrounding Statera Biopharma. By analyzing Statera Biopharma's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Statera Biopharma's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Statera Biopharma specific price patterns or momentum indicators. Please read more on our technical analysis page.
Statera Biopharma February 12, 2026 Technical Indicators
Most technical analysis of Statera help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Statera from various momentum indicators to cycle indicators. When you analyze Statera charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1988 | |||
| Market Risk Adjusted Performance | (4.68) | |||
| Mean Deviation | 33.71 | |||
| Semi Deviation | 21.85 | |||
| Downside Deviation | 66.41 | |||
| Coefficient Of Variation | 419.4 | |||
| Standard Deviation | 52.43 | |||
| Variance | 2748.4 | |||
| Information Ratio | 0.2365 | |||
| Jensen Alpha | 12.74 | |||
| Total Risk Alpha | 6.31 | |||
| Sortino Ratio | 0.1867 | |||
| Treynor Ratio | (4.69) | |||
| Maximum Drawdown | 275.0 | |||
| Value At Risk | (66.67) | |||
| Potential Upside | 100.0 | |||
| Downside Variance | 4409.72 | |||
| Semi Variance | 477.24 | |||
| Expected Short fall | (113.64) | |||
| Skewness | 1.72 | |||
| Kurtosis | 3.93 |
Statera Biopharma February 12, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Statera stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.00 | ||
| Daily Balance Of Power | Huge | ||
| Rate Of Daily Change | 2.00 | ||
| Day Median Price | 0.00 | ||
| Day Typical Price | 0.00 | ||
| Price Action Indicator | 0.00 |
Complementary Tools for Statera Pink Sheet analysis
When running Statera Biopharma's price analysis, check to measure Statera Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Statera Biopharma is operating at the current time. Most of Statera Biopharma's value examination focuses on studying past and present price action to predict the probability of Statera Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Statera Biopharma's price. Additionally, you may evaluate how the addition of Statera Biopharma to your portfolios can decrease your overall portfolio volatility.
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |